GSK declares $0.44/ADS or 17p/share dividend
Source: SeekingAlpha
2026-04-29 06:28:54 ET
More on GSK
- GSK: 'Strong Buy' On Mo-Rez Oncology Expansion Potential
- GSK: Chinese Expansion And Fine Financials
- GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript
- GSK posts Q1 beat as HIV and cancer drugs offset weakness in general medicines
- GSK beats top-line and bottom-line estimates; reaffirms FY26 and 2031 outlook
Read the full article on Seeking Alpha
For further details see:
GSK declares $0.44/ADS or 17p/share dividend
GSK plc American Depositary Shares (Each representing two)
NASDAQ: GSK
GSK Trading
-1.14% G/L:
$51.775 Last:
1,938,957 Volume:
$51.80 Open:
GSK Latest News
March 13, 2026 11:44:00 am
GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk
February 23, 2026 01:13:00 pm
Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
GSK Stock Data
$120,291,791,432
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London
